GUTS Fractyl Health Inc.

$GUTS everyone should thank for leading the guts community to the slaughter! He’s bashing $SLS which means that it will likely 10x

$GUTS I’m convinced that BIORICH is a paid account! He had unparalleled conviction on this stock which is down75% in 5 trading days as well bashing $SLS which is up 420% in the last year! He lead you all off a cliff! These are just facts. The scammer has me blocked so send this to him! BIOFRAUD! Good luck recovering your money to anyone who this conman, paid poster or total moron got to invest!

hey 👋 just trying to get your latest take on the $GUTS situation. I have been combing through your messages and it’s full of $SLS stuff. What’s the latest on your high conviction play?

$GUTS $SLS how come everyone is thumbs uppp ‘ing or commenting except for ? This was his number 1 conviction play and it’s justified to understand his latest strategy as he gabs about all other names. Maybe someone else on the board can direct me to his latest on guts? Tia

$GUTS The Viking bought GUTS at 1.38. All ya Apes! If you have GUTS and NUTS come and buy this stock $AMC $GME $OPEN $TSLA

$GUTS BIOFRAUD OWES YOU ALL AN APOLOGY! One month listening to this clown would turn your $1000 into $201!

$GUTS Can see data this week, possibly Friday AH with a Monday Call, paired with a Partnership or strategic investment announcement. Timing seems appropriate given $GUTS's previous milestones and data releases. Cheers!

$GUTS Thanks for bring this up. For those low lifes from the $SLS board trolling and accusing me of leading people down a path, I think this response to BG in September puts that to rest. I don't play games. And for those that do, would you expect a 60% drop in Share Price following $GUTS hitting stat. sig. In their Primary endpoint? $SLS folks, this can happen to you. $GUTS Stat. Sig. on primary and dropped 60%.

$GUTS $GUTS Upcoming binary event worth the risk IMO. Topline 6-month randomized data for the REMAIN-1 Pivotal Cohort is due any day. With the market cap sitting heavily depressed, any definitive positive readout can easily launch SP 3x-6x. Past data points to a successful phase 3: • 84% vs 46%: Patients who received a complete Revita ablation maintained up to 84% of their GLP-1 weight loss at one year, compared to just 46% for the sham group. • 40% Overall Reduction: Even across the modified intent-to-treat (mITT) group, Revita reduced weight regain by roughly 40%. • Flawless Safety: Zero device-related serious adverse events. The Pivotal trail was prospectively designed and statistically powered based on these exact metrics de-risking upcoming data. Maximum negativity surrounding ticker belies a reversal and multi-bagger move near term with positive catalysts. Combine positive data with a non-dilutive partner announcement and a violent fomo SP rerate would ensue.

$GUTS has lost all credibility. In January, they led with “70% less weight regain” from an exploratory subgroup of just 20 patients, even though the study wasn’t powered to prove efficacy. That data release is now part of a lawsuit alleging Revita’s prospects were overstated. Then came months of commercialization hype. The reverse split was framed as something the board could do if needed—and now they’ve chosen 1-for-12 before delivering the pivotal results shareholders were waiting for. After this, why should anyone believe another word they say? We’ve been strung along, blindsided, and left holding the consequences.

$GUTS CEO dropping Pertnership After Hours or Monday morning? I'm serious. In the hands of BP, data is sufficient for approval and adoption. NFA, but the potential remains.

$GUTS im not so sure they would care if shareholders suffer , theyre looking for their own best interest , like anyone would , shareholders are jyst collateral damage on their way to make themselves whole

$GUTS Hoping for minimally dilutive financing tied to data or performance milestones. Also hoping that new financing doesn’t come in offering large post-money stock packages to management and the board. Would be terrible if they were personally made whole through the dilution and the rest of the shareholders suffered. I am overdosing on hopium at this point LOL

$GUTS as much as I would like to hold, I have to make friends with the facts. Data sucked.

$GUTS "80% retention of GLP-1 induced weight loss vs 67% for sham" Is this 13% difference enough to run out to get this treatment? I assume the one year results will show further weight gain in the sham perhaps making the difference more pronounced.

$GUTS #yvyedge Premarket watchlist so far Happy Friday Reclaim $4.33 / retest / hold opens $4.45 / $4.54 / $4.75. Hold $4.18 / $4.08 underneath; lose those and $4.02 / $3.79 are back in play—clinical headline still unverified. $WSHP Needs $3.54 / $3.60 back for $3.82 / $3.94; lose $3.32 and watch $3.25. $25M equity facility carries dilution risk / 6M potential resale shares registered. $XLAB Strong bounce / clear $1.70 / retest / hold for $1.75 / $1.97 / $2.07. Hold $1.50 to keep momentum; below that watch $1.36 / $1.27—fresh news still unconfirmed

$GUTS I trust this management team about as much as a Nigerian prince promising me a $10 million inheritance. First, the January study debacle. Then weeks of presenting the reverse split as an “if needed” decision. Shareholders approve it September 24, and the board approves the 1-for-12 split THE SAME DAY. So much for “wait and see.” Now we’re supposedly on the verge of pivotal data, and the stock keeps bleeding. Add a securities lawsuit, financing concerns, and potential dilution. Quite the shareholder appreciation program. Even if the data is positive, who trusts this management anymore? At this point, the Nigerian prince might be the safer investment.

$GUTS frustrating they didn't even give it a chance to turnaround with data,like they proclaimed they would.

$GUTS fuck this whole company and all the grifters thieves and criminals that work there.

$GUTS Looks extremely undervalued to me. I’m going to do a little more reading and might start a position here.